Live Quote · NASDAQURGNHealthcare· Biotechnology

UroGen Pharma Ltd.

$27.65▼ 12.86%($-4.08)
MKT CAP $1.36BNEXT EARNINGS Mar 1, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
40
Valuation
60
Profitability
50
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a URGN research report →

Analyst Price Target
$58.60+111.9% vs. today

Range $44 – $75

Analyst RatingBuy
12 Buy4 Hold0 Sell

Price Chart

+25.56% · this period
$50.29$33.64$17.00Nov 19May 22Nov 19
52-Week Range32% of range
Low
$16.50
Current
$27.65
High
$50.81